217 related articles for article (PubMed ID: 24367617)
1. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
5. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
[TBL] [Abstract][Full Text] [Related]
6. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
[TBL] [Abstract][Full Text] [Related]
8. The role of chronic viral hepatitis on tuberculosis treatment interruption.
Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
[TBL] [Abstract][Full Text] [Related]
9. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
Merza MA; Haji SM; Alsharafani AM; Muhammed SU
Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
[TBL] [Abstract][Full Text] [Related]
16. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment.
Chien JY; Huang RM; Wang JY; Ruan SY; Chien YJ; Yu CJ; Yang PC
Int J Tuberc Lung Dis; 2010 May; 14(5):616-21. PubMed ID: 20392356
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia.
Richards DC; Mikiashvili T; Parris JJ; Kourbatova EV; Wilson JC; Shubladze N; Tsertvadze T; Khechinashvili G; del Rio C; Blumberg HM
Int J Tuberc Lung Dis; 2006 Apr; 10(4):396-401. PubMed ID: 16602403
[TBL] [Abstract][Full Text] [Related]
20. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
Puga MAM; Bandeira LM; Pompilio MA; Rezende GR; Soares LS; de Castro VOL; Tanaka TSO; Cesar GA; de Oliveira SMDVL; Teles SA; Yassuda RTS; Weis-Torres SMDS; BasÃlio SF; Croda J; Motta-Castro ARC
PLoS One; 2019; 14(8):e0221265. PubMed ID: 31437184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
